GnRH antagonist for patients with polycystic ovary syndrome undergoing controlled ovarian hyperstimulation for in vitro fertilization and embryo transfer in fresh cycles

被引:3
|
作者
Zhai, Xiang-Hong [1 ,2 ]
Zhang, Ping [2 ,3 ]
Wu, Feng-Xia [4 ]
Wang, An-Cong [2 ,3 ]
Liu, Pei-Shu [5 ]
机构
[1] Linyi Peoples Hosp, Dept Obstet & Gynecol, Linyi Hlth Sch, Linyi 276003, Shandong, Peoples R China
[2] Linyi Peoples Hosp, Dept Resp Med, 27 Jiefang Rd, Linyi 276003, Shandong, Peoples R China
[3] Linyi Peoples Hosp, Dept Obstet & Ginecol, Linyi 276003, Shandong, Peoples R China
[4] Shandong Univ, Dept Anat, Jinan 250012, Shandong, Peoples R China
[5] Shandong Univ, Qilu Hosp, Dept Obstet & Ginecol, Jinan 250012, Shandong, Peoples R China
关键词
polycystic ovary syndrome; in vitro fertilization and embryo transfer; gonadotrophin-releasing hormone antagonist; ovarian hyperstimulation syndrome; clinical pregnancy; fresh cycle; ENDOMETRIAL RECEPTIVITY; ANALOG; IVF; GONADOTROPINS; METAANALYSIS; THICKNESS;
D O I
10.3892/etm.2017.4309
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The aim of the present study was to evaluate the influence of a gonadotropin-releasing hormone (GnRH) antagonist compared with a GnRH agonist on the in vitro fertilization cycle outcome in patients with polycystic ovary syndrome. The outcomes of pregnancy were evaluated. The area under the curve (AUC) of the receiver operating characteristic (ROC) curve was also used to evaluate whether the endometrial thickness (cm) and estradiol (E-2) level (pg/ml) on the day of human chorionic gonadotropin (hCG) administration (the hCG day) had the best sensitivity and specificity for predicting a clinical pregnancy. The results demonstrated that there were significant differences in the E-2 and progesterone levels between the two treatment groups on the hCG day. Furthermore, the mean number of total oocytes retrieved, mean number of 2 pronuclei oocytes, mean number of oocytes cleaved (P< 0.05), mean number of embryos available (P= 0.022) and mean number of embryos transferred (P= 0.014) were significantly different. Additionally, the rates of ectopic pregnancy (P= 0.984) and ovarian hyperstimulation syndrome (P= 0.976) did not differ significantly between the treatment groups. Although the biochemical pregnancy (P= 0.592), clinical pregnancy (P= 0.617) and live birth (P= 0.365) rates were lower with the GnRH antagonist than with the GnRH agonist, there were no significant differences in the outcomes between the two groups. Analysis of the influence of endometrial thickness with respect to the clinical pregnancy using the ROC (AUC) method revealed that when the best cutoff of 9.75 cm was used, the sensitivity was 62.5%, the specificity was 43.1% and the AUC was 0.53. Additionally, the Youden index was 0.056. Analysis of the influence of the E-2 level on the hCG day on clinical pregnancy, using the ROC (AUC) method showed that the best cutoff was 2,984.5 pg/ml, which had a sensitivity of 68.8% and specificity of 52.9%, while the AUC was 0.573 (with a Youden index of 0.217). Furthermore, the results demonstrated that neither the endometrial thickness nor the E-2 level on the hCG day had the best sensitivity and specificity for predicting a clinical pregnancy.
引用
收藏
页码:3097 / 3102
页数:6
相关论文
共 50 条
  • [21] Serum retinol-binding protein-4 levels in polycystic ovary syndrome patients undergoing controlled ovarian hyperstimulation for in-vitro fertilization cycle
    Orvieto, R.
    Shuhat, V.
    Liberty, G.
    Homburg, R.
    Anteby, E. Y.
    Nahum, R.
    Rabinson, J.
    Meltcer, S.
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2010, 37 (02): : 100 - 104
  • [22] Polycystic ovarian syndrome (PCOS) patients have a favorable response to ganirelix acetate during controlled ovarian hyperstimulation (COH) for in vitro fertilization (IVF)-embryo transfer (ET).
    Bracero, N
    Jurema, M
    Vlahos, N
    Kolp, L
    Garcia, J
    FERTILITY AND STERILITY, 2002, 78 (03) : S149 - S150
  • [23] Does physicians' experience influence in vitro fertilization success in patients undergoing controlled ovarian hyperstimulation with GnRH antagonists?
    Orvieto, Raoul
    Rabinson, Jacob
    Meltcer, Simion
    Gemer, Ofer
    Anteby, Eyal Y.
    Zohav, Efraim
    FERTILITY AND STERILITY, 2008, 89 (03) : 736 - 737
  • [24] Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles
    Papanikolaou, EG
    Pozzobon, C
    Kolibianakis, EM
    Camus, M
    Tournaye, H
    Fatemi, HM
    Van Steirteghem, A
    Devroey, P
    FERTILITY AND STERILITY, 2006, 85 (01) : 112 - 120
  • [25] Outcomes of in vitro fertilization cycles among patients with polycystic ovary syndrome following ovarian puncture for in vitro maturation
    Lin, Jia
    Wang, Peiyu
    Zhao, Junzhao
    Xiao, Shiquan
    Yu, Rong
    Jin, Congcong
    Zhu, Ruru
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2016, 135 (03) : 319 - 323
  • [26] The Predictive Value of the Follicular Output Rate on Pregnancy Outcome of Patients with Polycystic Ovary Syndrome Undergoing In Vitro Fertilization and Embryo Transfer
    Yang, Haiyan
    Lin, Jia
    Jin, Congcong
    Meng, Lvhe
    Wu, Suichun
    Chen, Ya
    MEDICAL SCIENCE MONITOR, 2020, 26
  • [27] Fresh or Frozen Embryo Transfer in The Antagonist In Vitro Fertilization Cycles: A Retrospective Cohort Study
    Seyedoshohadaei, Fariba
    Rahmani, Khaled
    Allahveisi, Azra
    Rezaei, Masoumeh
    Rezaie, Mohammad Jafar
    Zandvakili, Farnaz
    Soufizadeh, Nasrin
    Honarbakhsh, Yasamin
    INTERNATIONAL JOURNAL OF FERTILITY & STERILITY, 2022, 16 (04) : 256 - 262
  • [28] Fertility of patients with polycystic ovary syndrome undergoing in vitro fertilization by age
    Hwang, Yu-Im
    Cha, Sun-Wha
    Song, In-Ok
    Yang, Kwang-Moon
    Min, Eung-Gi
    Kim, Hye-Ok
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2016, 135 (01) : 91 - 95
  • [29] Controlled Ovarian Hyperstimulation Adversely Affects Implantation Following In Vitro Fertilization–Embryo Transfer
    Jerome H. Check
    Jung K. Choe
    Diane Katsoff
    Donna Summers-Chase
    Carrie Wilson
    Journal of Assisted Reproduction and Genetics, 1999, 16 : 416 - 420
  • [30] Obstetric outcome of patients with polycystic ovary syndrome treated by in vitro maturation and in vitro fertilization and embryo transfer.
    Cha, KY
    Park, LS
    Kwon, H
    Chung, MK
    Chung, HM
    Yoon, TK
    FERTILITY AND STERILITY, 2004, 82 : S211 - S211